AMEX
0.26USD
+0.02 (+6.32%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
13.2M
P/E
—
EPS
—
Beta
0.69
52W range
0.177-1.45
Day range
0.24–0.27
Open
0.25
Prev close
0.25
Volume
729.3K
Avg volume
6.2M
Dividend
0.00
IPO
2023-07-24
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about AEON Biopharma, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for AEON: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
